Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Eyenovia and Senju Collaborate on Novel Dry Eye Treatment
Eyenovia, a leading ophthalmic company, announced a collaboration agreement with Senju Pharmaceutical to develop SJP-0035, a corneal epithelial wound healing candidate, using Eyenovia’s Optejet® dispensing technology for chronic dry eye disease treatment. Strategic Collaboration for Innovative Treatment Under the agreement,…
Johnson & Johnson Invests in Start-Up TECLens
Johnson & Johnson has recently finalized a strategic investment in TECLens, a pioneering start-up focused on advancing nonincisional refractive correction technology through corneal cross-linking (CXL). The investment, part of a co-leading effort in TECLens’ Series A funding round, underscores Johnson…
Bausch + Lomb Acquires Trukera Medical
Bausch + Lomb has completed the acquisition of Trukera Medical, a US-based ophthalmic medical diagnostic company. The financial details of the acquisition were not disclosed. Trukera Medical’s Innovative ScoutPro Device Trukera Medical, previously owned by private equity firm AccelMed Partners…
Oertli Receives FDA Clearance for Faros Anterior System
Oertli Instrumente AG announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its globally established Faros anterior cataract surgery system. This milestone underscores Oertli’s expansive global presence and unwavering commitment to delivering advanced and reliable…
Osheru Receives Funding for Ziplyft Device for Blepharoplasty
Osheru announced the successful completion of a $4.7 million funding round aimed at accelerating the development and commercialization of its Ziplyft device for blepharoplasty surgery. The funding round was oversubscribed and led by a consortium of investors including individuals, family…
New Research Unveils Uveal Melanoma Metastasis Mechanisms
New research from Edith Cowan University (ECU) is shedding light on the factors driving the metastasis of uveal melanoma, the deadliest form of eye cancer known for its high rate of spreading to the liver. Uveal Melanoma Overview and Metastasis…
Samsara Vision Launches SING IMT in China
Samsara Vision announced the successful completion of the first SING IMT (Smaller-Incision New-Generation Implantable Miniature Telescope) procedure in China. This milestone was achieved at the First Affiliated Hospital of Hainan Medical University Lecheng Hospital, where Professor Li Xiaorong, MD, PhD,…
Topcon and Orbis Partner to Expand DR Screening in Rwanda
Topcon Healthcare, in collaboration with Orbis International and the Rwanda International Institute of Ophthalmology (RIIO), has embarked on an initiative to enhance diabetic retinopathy screening in Rwanda. Donation of Robotic Retinal Cameras To facilitate this effort, Topcon has generously donated…
Meet Wilmer's Ophthalmic Residency Class of 2027 – Johns Hopkins Medicine
Meet Wilmer’s Ophthalmic Residency Class of 2027 Johns Hopkins Medicine Source: Author: | Date: 2024-07-23 07:00:00 Source: Author: | Date: 2024-07-23 07:00:00
Trial Results for Susvimo Show Sustained Efficacy in DME and DR
Genentech and Roche released compelling 2-year data from the phase 3 Pagoda and Pavilion studies evaluating Susvimo (ranibizumab injection) 100 mg/mL, marking a significant development in the treatment landscape for diabetic macular edema (DME) and diabetic retinopathy (DR). Reintroduction of…